Selection of Chemoradiotherapy Based on Response to Induction Chemotherapy - a Phase II Study in Locally Advanced Squamous Cell Carcinoma of Head and Neck.
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 13 Oct 2017
At a glance
- Drugs Everolimus (Primary) ; Cetuximab; Cisplatin; Paclitaxel
- Indications Head and neck cancer
- Focus Therapeutic Use
- 09 Oct 2017 Planned End Date changed from 1 Oct 2017 to 1 Oct 2018.
- 09 Oct 2017 Planned primary completion date changed from 1 Sep 2017 to 1 Aug 2018.
- 15 May 2017 Planned End Date changed from 1 May 2017 to 1 Oct 2017.